GlassScriptPhysician profile
Ronald J Rasansky
NPI 1447234539
$7,714.96
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,040 · 2020: $1,164 · 2021: $3,881 · 2022: $1,450 · 2023: $163 · 2024: $16.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $180.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $4,138.62 | 2019-2023 | |
| Abbvie INC. | $1,952.21 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $364.10 | 2019-2022 | |
| Janssen Biotech, INC. | $161.80 | 2019-2023 | Stelara |
| Takeda Pharmaceuticals U.S.A., INC. | $131.50 | 2019-2022 | |
| Ucb, INC. | $127.81 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $119.75 | 2021-2022 | |
| Intercept Pharmaceuticals, INC. | $115.31 | 2019-2022 | |
| Nestle Healthcare Nutrition INC. | $96.95 | 2020-2021 | |
| Celgene Corporation | $88.99 | 2021-2022 | |
| Braintree Laboratories, INC. | $72.10 | 2019-2021 | |
| Qol Medical, LLC | $70.67 | 2019-2020 | |
| Shionogi INC | $51.57 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $35.10 | 2021 | |
| Evoke Pharma, INC. | $34.93 | 2020-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $30.15 | 2022 | |
| W. L. Gore & Associates, INC. | $18.33 | 2021 | |
| Ardelyx, INC. | $17.50 | 2023 | Ibsrela |
| Pfizer INC. | $16.77 | 2021 | |
| Endogastric Solutions, INC | $16.71 | 2024 | Esophyx |
| Genzyme Corporation | $15.59 | 2022 | |
| Ironwood Pharmaceuticals, INC | $13.97 | 2023 | Linzess |
| Allergan, INC. | $12.62 | 2019 | |
| Concordia Pharmaceuticals INC. | $11.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Rasansky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.